January 16, 2025

Publication of White Paper on innovative drug discovery approach using Springer Nature’s literature data and FRONTEO’s specialized AI engine KIBIT

FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
May 13, 2024

FRONTEO, Shionogi, and Suzuken Collaborate to Implement Conversational Dementia Diagnosis Support AI Program in Society

FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.
September 18, 2018

Cracking the Character Code: Meeting the Asian Language E-Discovery Challenge

December 6, 2022

AI Review Tool “KIBIT Automator” Developing new AI algorithms

NEW YORK, December 6, 2022 – FRONTEO (TSE: 2158) has announced it has developed a new core algorithm for its AI review tool, "KIBIT Automator".
February 6, 2024

Launch of a New AI Drug Discovery Support Service analyzing data from 600 Springer Nature Journals

Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
January 30, 2024

Forensic Capability

We have enhanced our existing forensic services with new cutting-edge digital forensics software package, and we are working on adding more certified forensic experts to our staff.
March 15, 2023

U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies

U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
January 20, 2023

A comprehensive overview of FRONTEO’s brand-new eDiscovery document hosting platform

Earlier in 2022, FRONTEO was pleased to announce the release of its proprietary e-Discovery hosting platform called KIBIT Automator Review or KAMR.
April 29, 2019

FRONTEO Opens Low Cost Managed Review Center in Florida

March 14, 2019

FRONTEO Launches AI Review Solution “KIBIT Automator” that Improves Efficiency of Document Review

January 24, 2024

FRONTEO Holds On-site Seminar with Covington & Burling LLP and Nozomi Sogo Attorneys at Law

Explanation of points to keep in mind when Japanese companies negotiate with U.S. government agencies, crisis management, and the use of AI
September 26, 2023

Obtained a patent for a new technology for secure data transfer and analysis, which has become a hot topic for protecting data during cross-border transfer of confidential information in international lawsuits, etc.

NEW YORK, September 25, 2023 – FRONTEO (TSE: 2158) announces that it has received a patent application notice from the Japan Patent Office for a new technology that uses its proprietary AI engine "KIBIT" to analyze hashed¹⁾ confidential information that cannot be decrypted.
February 15, 2017

FRONTEO’s Lit i View Email Auditor Has Been Adopted By Global Container Shipping Company Evergreen Marine Corp.

September 9, 2022

U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies

U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
October 5, 2023

International Workshop on White Collar Crime Discussions with the U.S. Department of Justice and lawyers, etc will include Using AI and Other Technologies to Conduct Compliance and Investigations

NEW YORK, October 5, 2023 – FRONTEO (TSE: 2158) is pleased to announce that Shiho Tanaka, Global Sales Executive, LegalTech AI Division, FRONTEO, Inc and Senior Vice President, Data Science & Technology Department, FRONTEO USA, will be speaking at the 5th White Collar Crime Workshop 2023, organized by Daisuke Fukamizu of Nagashima Ohno & Tsunematsu, LLP.
April 17, 2020

FRONTEO Commences Drug Repositioning Research on Novel Coronavirus (COVID-19) Using Best-In-Class AI

January 30, 2017

Legal Industry Survey Reveals Growing Interest in Business Intelligence Applications

January 8, 2019

FRONTEO’s “Patent Explorer 19” Named Finalist for “Product Innovation Competition” in the upcoming Legalweek New York 2019

November 14, 2024

UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory

Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
June 27, 2023

FRONTEO Announces New Technology that Facilitates Analysis of Hashed Information with its Proprietary AI Engine “KIBIT”

NEW YORK, June 27, 2023 – FRONTEO (TSE: 2158) is pleased to announce it has developed a new technology that analyzes hashed data (patent pending) with its in-house developed AI engine "KIBIT".